EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Unveiling triterpenoid superiority in a newly developed Ganoderma lucidum variety through untargeted metabolomics approach

Zhibin Pan, Junhan Lin, Gelian Luo, Weiqing Cheng, Ye Li, Changhui Wu

Frontiers in Nutrition · 10.04.2025 · 12

DOI: 10.3389/fnut.2025.1541162 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Nutrition, online erschienen am 10.04.2025. Verfasst von Zhibin Pan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Vocational College of Bioengineering, Fuzhou, China. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The fruiting bodies of Ganoderma lucidum are renowned for their therapeutic properties, primarily due to their triterpenoid content. Variability in G. lucidum strains may influence the composition and abundance of triterpenoids. In this study, we explored the triterpenoid superiority in a newly developed G. lucidum strain (GL_V2) obtained through mutation breeding, and compared it to a widely cultivated strain (GL_V1). GL_V2 exhibited a 1.4-fold increase in total triterpenoid content and higher DPPH radical scavenging activity compared to GL_V1, while polysaccharide levels remained consistent. Using UPLC-Q-Orbitrap-MS and chemometric analyses, we identified 589 metabolites, including 86 triterpenoids. Multivariate statistical analyses revealed clear differences in overall metabolite profiles and triterpenoid compositions between the two strains. OPLS-DA identified 56 triterpenoids as key distinguishing markers with VIP values above 1.0. Notably, GL_V2 exhibited increased levels of seven ganoderic acids, two ganoderiols, three ganolucidic acids, and two ganosporelactones, while GL_V1 showed higher concentrations of six lucidenic acids. These results highlight the superior triterpenoid composition of GL_V2 and its potential for developing more potent G. lucidum -derived products. This study offers valuable insights into varietal differences in triterpenoid profiles and their implications for the cultivation and therapeutic use of G. lucidum . Additionally, the findings of this study suggest that GL_V2 holds significant potential for the development of more effective nutraceutical and pharmaceutical products derived from G. lucidum .

Schlagwörter

Stichwörter der Autor:innen

Ganoderma lucidumPCAUPLC-Q-Orbitrap-MSfruiting bodytriterpenoid profile

Autor:innen und Institutionen

  • Fujian Vocational College of Bioengineering, Fuzhou, China.
  • GanoHerb Co. Ltd., Fuzhou, China.

Zitieren

APA

Pan, Z., Lin, J., Luo, G., Cheng, W., Li, Y., & Wu, C. (2025). Unveiling triterpenoid superiority in a newly developed Ganoderma lucidum variety through untargeted metabolomics approach. Frontiers in Nutrition, 12. https://doi.org/10.3389/fnut.2025.1541162

Vancouver

Pan Z, Lin J, Luo G, Cheng W, Li Y, Wu C. Unveiling triterpenoid superiority in a newly developed Ganoderma lucidum variety through untargeted metabolomics approach. Frontiers in Nutrition. 2025;12. doi:10.3389/fnut.2025.1541162

BibTeX
@article{Pan2025,
  author = {Pan, Zhibin and Lin, Junhan and Luo, Gelian and Cheng, Weiqing and Li, Ye and Wu, Changhui},
  title = {Unveiling triterpenoid superiority in a newly developed Ganoderma lucidum variety through untargeted metabolomics approach},
  journal = {Frontiers in Nutrition},
  year = {2025},
  volume = {12},
  doi = {10.3389/fnut.2025.1541162}
}
Kostenlos starten →